From r-help-bounces@stat.math.ethz.ch  Fri Jun 15 15:04:58 2007
Return-Path: <r-help-bounces@stat.math.ethz.ch>
Received: from hypatia.math.ethz.ch (hypatia.math.ethz.ch [129.132.145.15])
	by flax9.uwaterloo.ca (8.12.8/8.12.5) with ESMTP id l5FJ4uL9005707
	for <ktwarwic@flax9.uwaterloo.ca>; Fri, 15 Jun 2007 15:04:57 -0400
Received: from hypatia.math.ethz.ch (hypatia [129.132.145.15])
	by hypatia.math.ethz.ch (8.13.6/8.13.6) with ESMTP id l5FJ3OnR014280;
	Fri, 15 Jun 2007 21:03:41 +0200
X-Spam-Checker-Version: SpamAssassin 3.2.0 (2007-05-01) on hypatia.math.ethz.ch
X-Spam-Level: 
X-Spam-Status: No, score=-0.4 required=5.0 tests=AWL,
	DKIM_POLICY_SIGNSOME autolearn=no version=3.2.0
Received: from out4.smtp.messagingengine.com (out4.smtp.messagingengine.com
	[66.111.4.28])
	by hypatia.math.ethz.ch (8.13.6/8.13.6) with ESMTP id l5FJ3DKH014190
	for <r-help@stat.math.ethz.ch>; Fri, 15 Jun 2007 21:03:14 +0200
Received: from compute1.internal (compute1.internal [10.202.2.41])
	by out1.messagingengine.com (Postfix) with ESMTP id A3250CAD
	for <r-help@stat.math.ethz.ch>; Fri, 15 Jun 2007 15:03:13 -0400 (EDT)
Received: from web5.messagingengine.com ([10.202.2.214])
	by compute1.internal (MEProxy); Fri, 15 Jun 2007 15:03:13 -0400
Received: by web5.messagingengine.com (Postfix, from userid 99)
	id 83B1725167; Fri, 15 Jun 2007 15:03:13 -0400 (EDT)
Message-Id: <1181934193.4957.1195396717@webmail.messagingengine.com>
X-Sasl-Enc: ieh+sxeneHQaGioNwP7e2/f8uLGbX0yqu/NhkR7VMb5r 1181934193
From: "Nicholas Lewin-Koh" <nikko@hailmail.net>
To: r-help@stat.math.ethz.ch
Content-Disposition: inline
MIME-Version: 1.0
X-Mailer: MessagingEngine.com Webmail Interface
Date: Fri, 15 Jun 2007 15:03:13 -0400
X-Virus-Scanned: by amavisd-new at stat.math.ethz.ch
Subject: [R] R vs. Splus in Pharma/Devices Industry
X-BeenThere: r-help@stat.math.ethz.ch
X-Mailman-Version: 2.1.9
Precedence: list
List-Id: "Main R Mailing List: Primary help" <r-help.stat.math.ethz.ch>
List-Unsubscribe: <https://stat.ethz.ch/mailman/listinfo/r-help>,
	<mailto:r-help-request@stat.math.ethz.ch?subject=unsubscribe>
List-Archive: <https://stat.ethz.ch/pipermail/r-help>
List-Post: <mailto:r-help@stat.math.ethz.ch>
List-Help: <mailto:r-help-request@stat.math.ethz.ch?subject=help>
List-Subscribe: <https://stat.ethz.ch/mailman/listinfo/r-help>,
	<mailto:r-help-request@stat.math.ethz.ch?subject=subscribe>
Content-Type: text/plain; charset="us-ascii"
Content-Transfer-Encoding: 7bit
Sender: r-help-bounces@stat.math.ethz.ch
Errors-To: r-help-bounces@stat.math.ethz.ch

Hi,
I just saw this thread. This issue, and the larger scale issue of open
source in industry
is being addressed. One has to realize that the behemoth that is the
clinical aperatus
of the pharma industry is very conservative and very slow to change. In
many cases 
switching to R would meean changing a great many processes all based on
legacy code. One
of the big issues is that the industry demands consistency not
necessarily correctness.

All that said there are a great many areas where R could be used that
would not impact
regulatory submission, data security etc. Many in pharma are quietly
working on this,
but steps are small and incremental. Development takes time in industry
because of the amount of
documentation necessary. All this impacts the "free" nature of R and
cost and risk (From the industries
perspective) need to be justified. 

Probably when the statistical community is using Z big pharma will be
ready to use
R. %P

Nicholas

______________________________________________
R-help@stat.math.ethz.ch mailing list
https://stat.ethz.ch/mailman/listinfo/r-help
PLEASE do read the posting guide http://www.R-project.org/posting-guide.html
and provide commented, minimal, self-contained, reproducible code.

